These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)]. Colin J; Chastel C Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719 [TBL] [Abstract][Full Text] [Related]
5. Vidarabine therapy of complicated herpes simplex keratitis. O'Day DM; Poirier RH; Jones DB; Elliott JH Am J Ophthalmol; 1976 May; 81(5):642-9. PubMed ID: 1275044 [TBL] [Abstract][Full Text] [Related]
6. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU]. Oshima K Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686 [No Abstract] [Full Text] [Related]
8. Ocular and systemic antiviral activity of vidarabine. Pavan-Langston D; Hess F Compr Ther; 1977 Jul; 3(7):42-8. PubMed ID: 195767 [No Abstract] [Full Text] [Related]
9. Therapy of experimental herpes simplex keratitis in rabbits with 5-lodo-5'-amino-2',5'-dideoxyuridine (39882). Puliafito CA; Robinson NL; Albert DM; Pavan-Langston D; Lin TS; Ward DC; Prusoff WH Proc Soc Exp Biol Med; 1977 Oct; 156(1):92-6. PubMed ID: 198822 [No Abstract] [Full Text] [Related]
10. [Arabinosyladenine in ophthalmology (author's transl)]. Colin J J Fr Ophtalmol; 1981; 4(6-7):525-30. PubMed ID: 7028853 [TBL] [Abstract][Full Text] [Related]
11. Light intensity on the photodynamic inactivation of herpes simplex keratitis. Stanley JA; Pinnolis M Am J Ophthalmol; 1976 Mar; 81(3):332-6. PubMed ID: 176890 [No Abstract] [Full Text] [Related]
12. Ara-A and IDU therapy of human superficial herpetic keratitis. Laibson PR; Hyndiuk R; Krachmer JH; Schultz RO Invest Ophthalmol; 1975 Oct; 14(10):762-3. PubMed ID: 1102484 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Smith KO; Kennell WL; Poirier RH; Lynd FT Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967 [TBL] [Abstract][Full Text] [Related]
14. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis. Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952 [TBL] [Abstract][Full Text] [Related]
15. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis. Fardeau C; Langlois M; Mathys B; Rafales P; Nugier F; Godard V; Aymard M; Denis J Curr Eye Res; 1991; 10 Suppl():151-8. PubMed ID: 1650663 [TBL] [Abstract][Full Text] [Related]
16. Antiviral drugs for herpes simplex keratitis. Soll DB; Obrotka TM Am Fam Physician; 1977 Dec; 16(6):116-7. PubMed ID: 412404 [No Abstract] [Full Text] [Related]
17. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085 [TBL] [Abstract][Full Text] [Related]
18. Ara AMP- a highly soluble new antiviral drug. Pavan-Langston D; North RD; Geary PA Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940 [TBL] [Abstract][Full Text] [Related]